Brief: Jagsonpal Pharmaceuticals Board Approves Equity Share Buyback Proposal
12/03/2026 08:28
March 12 (Reuters) - Jagsonpal Pharmaceuticals Ltd JGSN.NS: BOARD APPROVES EQUITY SHARE BUYBACK PROPOSAL BUYBACK PRICE SET AT 250 RUPEES PER EQUITY SHARE MAXIMUM BUYBACK OFFER SIZE IS 400 MILLION RUPEES Source text: ID:nBSE1dm7FV Further company coverage: JGSN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jagsonpal Pharmaceuticals
See all newsIndia's Jagsonpal Pharma jumps on purchase of wellness portfolio of Group Pharma
Brief: Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals
Brief: Jagsonpal Pharmaceuticals Passes Buy-Back Resolution
Brief: Jagsonpal Pharmaceuticals Gets Order For Tax Demand Of 48.2 Million Rupees
India's Jagsonpal Pharmaceuticals jumps after plan to buyback shares